Systematic Review and Meta-Analysis of Inflammatory Bowel Disease Adverse Events with Anti-Interleukin 17A Agents and Tumor Necrosis Factor Inhibitors in Rheumatic Disease and Skin Psoriasis.

Truong, Steven L; Chin, Jasmine; Liew, David F L; Zahir, Syeda Farah; Ryan, Elizabeth G; Rubel, Diana; Radford-Smith, Graham; Robinson, Philip C

Truong, Steven L; Chin, Jasmine; Liew, David F L; Zahir, Syeda Farah; Ryan, Elizabeth G; Rubel, Diana; Radford-Smith, Graham; Robinson, Philip C.

Afiliação

Truong SL; Department of Medicine, Griffith University, Brisbane, QLD, Australia.
Chin J; Coast Joint Care, Maroochydore, QLD, Australia.
Liew DFL; Faculty of Medicine, University of Queensland, Brisbane, QLD, Australia.
Zahir SF; Department of Medicine, University of Melbourne, Parkville, Australia.
Ryan EG; Department of Clinical Pharmacology and Therapeutics, Austin Health, Heidelberg, VIC, Australia.
Rubel D; Department of Rheumatology, Austin Health, Heidelberg, VIC, Australia.
Radford-Smith G; QCIF Facility for Advanced Bioinformatics, Institute for Molecular Bioscience, The University of Queensland, Brisbane, QLD, Australia.
Robinson PC; Faculty of Medicine, University of Queensland, Brisbane, QLD, Australia.

Rheumatol Ther ; 8(4): 1603-1616, 2021 Dec.

Article em En | MEDLINE | ID: mdl-34449067

Palavras-chave

Anti-interleukin-17; Anti-tumor necrosis factor; Axial spondyloarthritis; Crohn's disease; Inflammatory bowel disease; Meta-analysis; Pharmacovigilance; Psoriasis; Psoriatic arthritis; Ulcerative colitis

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2021 Tipo de documento: Article